Condition
Mucosal Inflammation
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Unknown2
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05106738Completed
Phase Angle and Chronic Intestinal Inflammatory Diseases
NCT04814927Phase 4CompletedPrimary
Impact of Contraceptives on Cervico-Vaginal Mucosa
NCT03444675Unknown
The Endoscopic Assesment of Intestinal Grafts
NCT03598881Not ApplicableCompleted
A Study to Assess the Impact of a Non-SLS Toothpaste Upon Oral Mucosal Desquamation
NCT03108079Not ApplicableUnknown
Bladder Morphology Using 2 Different Catheter Designs
NCT01562951Phase 3Terminated
Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants
Showing all 6 trials